KELLY MIXON: Open Payments
NPI 1376121426 · THOMASVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,205 in 61 payments from 15 companies in 2025. Trend: 2023 $914 · 2024 $805 · 2025 $1,205
Food & beverage: $1,205
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 10 | $242 |
| CVRx, Inc. | 7 | $153 |
| AstraZeneca Pharmaceuticals LP | 8 | $145 |
| Amgen Inc. | 9 | $142 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $107 |
| ABIOMED | 1 | $79 |
| E.R. Squibb & Sons, L.L.C. | 5 | $79 |
| Merck Sharp & Dohme LLC | 4 | $74 |
| BridgeBio Pharma, Inc. | 3 | $52 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $44 |
Products named: LEQVIO, Barostim Neo System, REPATHA, JARDIANCE, FARXIGA, VERQUVO, Attruby, ELIQUIS.
Industry payments across GA — which companies pay providers there.
